Emergent BioSolutions EBS Cash Flow Statement (2010-2026)

NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT
Reported Financials

Emergent BioSolutions Quarterly Cash Flow Statement

Periods 64 quarters
Latest Jun 2026

Emergent BioSolutions reported cash from operations of $56.10M and free cash flow of $54.00M for the quarter ended Jun 2026, down 47.3% year over year. This cash flow statement covers 64 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-32.70M177.90M-3.70M-56.40M-87.10M-67.00M-186.20M-261.40M-263.40M-49.50M9.00M-283.10M114.80M-31.30M68.00M-12.00M51.20M-54.60M6.80M-180.20M
Share-based CompensationStock Comp.
10.40M10.10M9.90M12.30M11.20M11.70M6.80M8.30M4.00M4.00M5.90M5.50M2.30M4.30M1.50M4.60M4.80M5.30M2.80M6.00M
Deferred Taxes
3.80M45.40M1.90M0.70M22.90M-54.10M-4.70M-1.70M2.70M-5.20M-12.20M-0.20M7.30M-0.40M18.60M-13.90M-10.20M1.50M-4.50M2.10M
Gains from Investment SecuritiesGains Investment
0.90M0.30M0.50M1.30M0.60M0.20M0.30M0.40M-1.10M0.60M0.50M0.10M2.20M-9.50M7.30M-8.40M-0.50M
Asset Writedowns and ImpairmentWritedown
306.70M27.20M12.20M191.30M
Cash from OperationsCash from Ops.
16.70M328.10M-37.30M-15.60M-74.00M92.80M-184.00M-114.40M60.00M32.10M-62.60M47.50M153.70M-79.90M-11.20M106.40M-2.30M77.70M-33.80M56.10M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
1.10M1.00M1.00M1.00M1.10M1.00M1.00M8.90M5.70M5.70M6.90M5.00M-6.70M2.20M2.30M2.40M2.50M2.60M1.80M1.60M
Depreciation & Amortization (CF)Dep. & Amort.
32.70M29.20M30.90M44.50M32.20M35.70M34.60M32.90M28.00M29.60M27.90M28.50M26.40M26.00M25.40M23.50M23.40M23.50M23.50M24.00M
Change in Working Capital
Change in ReceivablesChange Receivables
80.00M-98.50M-93.70M-4.00M15.20M-35.60M-2.60M132.40M-71.30M-36.90M50.00M-20.40M-82.30M77.10M73.30M-118.50M71.60M-51.90M38.90M68.80M
Change in InventoryChange Inventory
-21.70M8.60M50.10M25.40M27.30M-127.70M30.70M-5.80M0.10M-25.60M4.50M13.00M18.00M-11.00M2.20M24.70M17.60M-14.20M-15.80M-24.00M
Change in Account PayablesChange Payables
-4.50M-5.10M-14.70M7.10M-4.20M-2.20M31.00M-20.10M6.80M-7.10M-2.40M2.60M-23.00M-10.20M-5.40M-10.40M-4.00M11.40M-14.40M10.00M
Change in Accured ExpensesChange Accured Exp.
36.10M10.10M-51.00M14.60M-12.00M-18.30M-24.30M10.50M-16.40M-25.50M-33.30M26.30M39.90M-51.10M-32.20M3.90M1.30M9.70M-20.20M4.20M
Change in TaxesChange Taxes
-5.50M-40.90M-4.60M79.70M12.90M1.30M-17.70M-12.70M16.10M10.50M-3.30M-8.40M6.80M6.20M-6.30M4.60M-0.30M
Other Working Capital ChangesOther WC Changes
400.00M-12.30M-2.00M4.70M1.50M5.40M-8.40M0.70M9.50M4.10M-19.70M0.20M0.70M-1.50M-0.30M0.20M1.20M4.10M3.20M3.30M
Investing Activities
Capital ExpendituresCapex
55.20M45.80M32.20M32.10M179.40M15.10M12.50M12.60M11.40M10.80M4.60M5.80M1.70M3.60M2.90M3.40M3.90M2.40M2.10M
Sales of Property, Plant and EquipmentPP&E (Sale)
7.60M0.30M38.10M0.10M0.20M
Acquisitions
Divestments
74.90M
Change in Acquisitions & DivestmentsChange Acquisitions
Cash from Investing ActivitiesCash from Investing
-55.20M-45.80M-32.20M-32.10M-271.60M-45.40M-15.10M257.70M-18.90M-11.40M-10.80M-4.60M112.00M28.60M59.50M17.20M-3.40M-3.90M-2.40M-52.30M
Financing Activities
Other financing activitiesOther financing
2.50M3.40M0.50M2.50M2.00M1.30M0.50M0.70M12.70M0.10M0.70M-0.80M1.40M
Cash from Financing ActivitiesCash from Financing
-5.00M-110.00M-70.50M-30.70M229.30M353.10M-10.50M-486.90M-43.00M4.70M40.70M-50.90M-180.30M0.50M-0.40M-6.40M-15.90M-113.90M-11.40M-24.40M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.20M-1.00M0.40M
Additional items
Exchange Rate EffectFX Effect
-0.20M-6.10M-0.30M0.70M-1.00M1.10M-0.20M-0.60M1.10M-1.50M-0.70M1.00M-0.20M
Change in Cash
-43.70M172.30M-140.30M-77.70M-117.30M401.60M-209.80M-344.20M-0.80M23.90M-32.70M-8.00M85.40M-50.80M47.20M118.20M-21.80M-40.10M-47.60M-20.60M
Free Cash FlowFCF
-38.50M282.30M-69.50M-47.70M-253.40M92.80M-199.10M-126.90M47.40M20.70M-73.40M42.90M147.90M-81.60M-14.80M103.50M-5.70M73.80M-36.20M54.00M
Net Cash FlowNCF
-43.50M172.30M-140.00M-78.40M-116.30M400.50M-209.60M-343.60M-1.90M25.40M-32.70M-8.00M85.40M-50.80M47.90M117.20M-21.60M-40.10M-47.60M-20.60M

Emergent BioSolutions Cash Flow Statement API

Pull Emergent BioSolutions's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EBS&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY